Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Mexikó

4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Where

  Mexico City, Monterrey, Morelia, Oaxaca City, Pachuca, Torreón

  Életkor

  18 év and over

  People

  1046 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06717347 · EU 2024-515566-13-00
• 2/3. fázisTaking people
  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Where

  Chihuahua City, Mexico City

  Életkor

  18 év and over

  People

  290 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05139017 · EU 2022-502646-27-00
• 2. fázisTaking people
  Low Dose Epcoritamab Plus GemOx in R/R DLBCL

  Where

  Monterrey

  Életkor

  18 év to 65 év

  People

  10

  Run by

  Hospital Universitario Dr. Jose E. Gonzalez

  See details and how to joinNCT07451652
• No phaseTaking people
  Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  Where

  Huixquilucan de Degollado, Mexico City

  Életkor

  18 év and over

  People

  700 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06830759